Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/31/2009US20090326020 Compounds for treatment of cancer
12/31/2009US20090326019 3,4-bicyclic pyrrolidine antivirals
12/31/2009US20090326018 2-Phenyl indene derivatives useful as estrogen receptor ligands
12/31/2009US20090326017 Pain-relieving compositions and uses therefor
12/31/2009US20090326015 Compounds with embedded benzopyran motif for core structures and preparation method thereof
12/31/2009US20090326014 Use of 5-ht7 receptor agonists for the treatment of pain
12/31/2009US20090326013 Isomers of inositol niacinate and uses thereof
12/31/2009US20090326012 Malononitrile Compounds
12/31/2009US20090326011 Azab i cyclo [3 . 1 . 0] hexane derivatives as dopamin d3 receptor modulators
12/31/2009US20090326010 Piperidinyl derivative as a modulator of chemokine receptor activity
12/31/2009US20090326009 Novel 1-2-Dihydroquinoline Derivative Having Glucocorticoid Receptor Binding Activity
12/31/2009US20090326008 NF-kappa B Inhibitor
12/31/2009US20090326007 Compounds and methods for modulating sir2 protein activity
12/31/2009US20090326006 Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors
12/31/2009US20090326005 Quinine sulfate/bisulfate solid complex; methods of making; and methods of use thereof
12/31/2009US20090326004 Muscarinic receptor antagonists
12/31/2009US20090326003 Pyrazolo (3, 4-b) pyridine derivatives as pde4 inhibitors
12/31/2009US20090326002 Thieno [2,3-b] Pyridine Compounds with mGluR Activity
12/31/2009US20090326001 Thienopyridine derivatives as modulators of metabotropic glutamate receptors
12/31/2009US20090326000 Resveratrol formulations and methods of use
12/31/2009US20090325999 Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
12/31/2009US20090325997 Pharmaceutical Compositions For The Treatment Of Capillary Arteriopathy
12/31/2009US20090325996 Camptothecin derivatives and their use
12/31/2009US20090325995 Mixing a water-insoluble opioid, a water-soluble carrier, and a solvent for each of the opioid and the carrier; spray-drying the mixture to remove the solvent and obtain a substantially solvent-free nanodispersion of the opioid; in the carrier; oral administration; drug delivery
12/31/2009US20090325994 Methods of treating diarrhea caused by small intestinal bacterial overgrowth
12/31/2009US20090325993 GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric Disorders
12/31/2009US20090325992 Compound having cyclic group bound thereto through spiro binding and use thereof
12/31/2009US20090325991 Spirolactam Bicyclic CGRP Receptor Antagonists
12/31/2009US20090325990 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
12/31/2009US20090325989 Indazolyl derivatives useful as potassium channel modulating agents
12/31/2009US20090325988 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof
12/31/2009US20090325987 Quinazolinedione derivatives as trpa1 modulators
12/31/2009US20090325986 Deazapurine Analogs of 1'-Aza-L-Nucleosides
12/31/2009US20090325985 Diketopiperidine Derivatives as HIV Attachment Inhibitors
12/31/2009US20090325984 Use of 1,7-dimethylxanthine for the manufacture of a non-anxiogenic psychoanaleptic drug for the treatment of a neuropsychiatric disorder
12/31/2009US20090325983 New purine derivatives
12/31/2009US20090325982 Phosphodiesterase 4 inhibitors
12/31/2009US20090325981 Compounds and compositions as lxr modulators
12/31/2009US20090325980 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds
12/31/2009US20090325979 Novel imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof
12/31/2009US20090325978 Stable lyophilized preparation
12/31/2009US20090325977 Cancer combination therapy comprising azd2171 and imatinib
12/31/2009US20090325976 Prostacyclin derivatives
12/31/2009US20090325975 Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain
12/31/2009US20090325974 1,5-diphenylpyrazoles ii as hsp90 inhibitors
12/31/2009US20090325973 Formulations containing pyridazine compounds
12/31/2009US20090325972 Novel cinnamaldehyde derivatives having improved solubility in water, a method for preparing the same and a pharmaceutical composition comprising the same
12/31/2009US20090325971 Pentacyclic Alkaloid Compounds and Methods of Use Thereof
12/31/2009US20090325970 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
12/31/2009US20090325969 Methotrexate adjuvants to reduce toxicity and methods for using the same
12/31/2009US20090325968 Compositions Useful as Inhibitors of Protein Kinases
12/31/2009US20090325967 Adenosine derivatives as a2a receptor agonists
12/31/2009US20090325966 s-Triazine compounds, pharmaceutical compositions and method of using the same
12/31/2009US20090325964 Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression
12/31/2009US20090325963 charged curcuminoid such as bisdemethoxycurcumin, curcumin and glycinates, as well as hybrid compounds of bisdemethoxycurcumin and resveratrol, fisetin, or honokiol; bioavailability
12/31/2009US20090325962 Tyrosine derivative
12/31/2009US20090325961 INDANE MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
12/31/2009US20090325960 Method for treating inflammatory diseases using rho kinase inhibitor compounds
12/31/2009US20090325959 Method for treating ophthalmic diseases using rho kinase inhibitor compounds
12/31/2009US20090325958 Method for treating pulmonary diseases using rho kinase inhibitor compounds
12/31/2009US20090325957 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
12/31/2009US20090325956 Aromatic amine derivative and use thereof
12/31/2009US20090325955 Gyrase inhibitors and uses thereof
12/31/2009US20090325954 2-benzimidazolyl-6-morpholino-4-phenylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
12/31/2009US20090325953 P38 kinase inhibiting agents
12/31/2009US20090325952 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
12/31/2009US20090325951 Thienyl-and furanyl-isoquinolinones and methods for using them
12/31/2009US20090325950 Benzoxazine derivatives and uses thereof
12/31/2009US20090325949 5 ht receptor mediated neurogenesis
12/31/2009US20090325948 Inhibitors of undecaprenyl pyrophosphate synthase
12/31/2009US20090325947 Nitrate esters of piperidines
12/31/2009US20090325946 Novel phenolic and catecholic amines and prodrugs thereof
12/31/2009US20090325945 Imidazo[4, 5-b]pyridin-2-one and oxazolo[4, 5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
12/31/2009US20090325944 Methods and Compositions for Modulating Glycosylation
12/31/2009US20090325943 Veterinary pharmaceutical compositions for the treatment of pain and inflammation
12/31/2009US20090325942 Phenothiazin derivates, method for the production thereof and use thereof as pharmaceuticals
12/31/2009US20090325941 Novel 2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes
12/31/2009US20090325940 Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof
12/31/2009US20090325939 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
12/31/2009US20090325938 Controlled-release cns modulating compositions and methods for the treatment of otic disorders
12/31/2009US20090325937 Pyridazine Compounds as Glycogen Synthase Kinase 3 Inhibitors
12/31/2009US20090325936 Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
12/31/2009US20090325935 Gyrase inhibitors and uses thereof
12/31/2009US20090325934 Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds
12/31/2009US20090325933 Pyrimidinone Derivatives and Their Use as a Drug
12/31/2009US20090325932 4-piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
12/31/2009US20090325931 Use of cdk inhibitors for the treatment of granulocyte mediated disorders
12/31/2009US20090325930 Selective estrogen receptor modulator
12/31/2009US20090325929 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof
12/31/2009US20090325928 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors
12/31/2009US20090325927 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor
12/31/2009US20090325926 Pyrrolo[3,2-d] pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus
12/31/2009US20090325925 Thiophenes and uses thereof
12/31/2009US20090325924 GPCR Agonists
12/31/2009US20090325923 New method for the treatment of inflammatory diseases
12/31/2009US20090325921 Method of improving the overall health of a patient with use of a transdermal dhea cream and/or dhea sulfate cream
12/31/2009US20090325920 Methods for the treatment of a traumatic central nervous system injury
12/31/2009US20090325919 Method of preparation of a soluble formulation of water-insoluble pentacyclic and tetracyclic terpenoids, a soluble formulation of a pentacyclic or tetracyclic terpenoid and a pharmaceutical composition containing this soluble formulation
12/31/2009US20090325918 Synthesis and separation of optically active isomers and cyclopropyl derivatives of spironolactone and their biological action
12/31/2009US20090325917 Pharmaceutical Compositions and Nasal Spray Incorporating Anhydrous Mometasone Furoate
1 ... 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 ... 7860